Gilead’s Hunt And The Crispr Crapshoot (Podcast) – Seeking Alpha
|
Gilead's Hunt And The Crispr Crapshoot (Podcast)
Seeking Alpha M&A in the pharma industry is often nothing more than a roll of the dice. CRISPR Therapeutics' stock has shot up in the last two months with little or no obvious explanation. Could Gilead Sciences be lurking? That's BioSci Capital Partners' recent … |
